ARCHIVES

Clearinghouse Opens With Predictable Controversy; Brown Urges ‘Open Minds’

This article is from The Cancer Letter archive.

Vol. 02 No. 46 | November 12, 1976

Download PDF Visit The Full Archive

Related Articles

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

FDA Approves Generic Capecitabine

September 20, 2013

AACR Cancels $7 Million Annual Meeting, Citing Fear of SARS in Toronto

April 4, 2003

Study: Delaying ADT Until Symptoms Appear Can Be Safe in Men with a PSA-based Relapse

May 30, 2014

Bush Appoints Kripke To President’s Cancer Panel

March 21, 2003